So do we focus on & secure only what's needed to get to doctor precriptions....& say --- hey world, have @ it, Cytodyn does not care what "you" are prescribing for, because it is all the same production volume regardless of any corporate licensing deals.
A liscense deal is simply a $$ advancement, on what revenue will be generated regardless. With the developing scale now occuring for our Platform drug, I think trying to slam out A-typical type deals, is a headache & MANY speed bumps.
Get Leronlimab known to the world. Prescriptions. Cytodyn simply fills orders.
1m % easier for Cytodyn then the Who, What, When, how much, what %, etc. etc.
Mfgr'ng LL & distributing.
By-pass old, cumbersome & expensive routes of negotiations, monitoring, hiring, etc., etc.. Cytodyn grows & grows very fast
LL / ICI :
We do a few Exclusive Rights for upfront $$ from each.
Tiered payments & let each entity / consortium, handle the combos
...